Moving Precision Oncology for Advanced Prostate Cancer from Theory to Practice. Academic Article uri icon

Overview

abstract

  • Genomic profiling represents the first clinical practice-ready tool for precision oncology in metastatic prostate cancer. Here we outline current testing considerations and gray zones regarding how best to apply genomic testing in the clinic. The lessons we learn today will continue to shape how we integrate evolving biology and future technologies into practice.

publication date

  • August 20, 2022

Research

keywords

  • Precision Medicine
  • Prostatic Neoplasms

Identity

PubMed Central ID

  • PMC11832036

Scopus Document Identifier

  • 85136266444

Digital Object Identifier (DOI)

  • 10.1016/j.euf.2022.08.004

PubMed ID

  • 35999168

Additional Document Info

volume

  • 9

issue

  • 1